Mental Help Net
Diabetes
Resources
Basic InformationMore InformationLatest News
Drug May Reverse Type 1 Diabetes Ocular ComplicationsClinical Trials Update: Nov. 16, 2009Factors Linked to Postpartum Diabetes IdentifiedTargeted Therapies in Diabetic Nephropathy ExaminedFDA Warns Exenatide Could Cause Kidney ProblemsFDA Issues Warning for Diabetes DrugAdherence Linked to Glycemic Control in Youth With DiabetesAmericans Get Failing Grade on Diabetes AwarenessVeggies in Pregnancy Lowers Child's Diabetes RiskLifestyle Changes Can Reduce Incidence of DiabetesDiet, Exercise Thwart Diabetes: StudyAAO: Myopia May Reduce Risk of Diabetic RetinopathyHealth Tip: Foot Care for People With DiabetesStudy Examines Adding Insulin to Oral Antidiabetic TherapyLong-Acting Insulin Works Best for Many DiabeticsRed-Grape Compound May Improve DiabetesDiabetes May Not Influence Heart Disease OutcomesHealthier Neighborhoods Help Keep Diabetes at BayBody Clock, Blood Sugar Control Seem LinkedHealth Tip: Understanding Gestational DiabetesVisual Loss Lower in Recently Diagnosed Type 1 DiabeticsT'ai Chi Program May Benefit Type 2 Diabetes PatientsWeight Loss Tied to Improved Sleep Apnea in DiabeticsKidney Disease Risk May Be Higher in Allergic DiabeticsFemale Diabetics More Likely to Develop Atrial FibrillationTreating Gestational Diabetes Can Reduce Fetal OvergrowthImaging Modalities for Heart Disease in Diabetics ComparedType 2 Diabetes Drug May Increase Fracture RiskIrregular Heartbeat Risk Higher in Women With Type 2 DiabetesFat Hormone May Improve Insulin Sensitivity in DiabeticsDiscovery May Pave Way to Better Diabetes Care
Blog EntriesVideosLinks
Community

Talk about this issue in our mental health support community

Therapist Search
Find a Therapist:
 (USA/CAN only)

Use our Advanced Search to locate a therapist outside of North America.

Related Topics

Medical Disorders

FDA Warns Exenatide Could Cause Kidney Problems

(HealthDay News)
by -- Andrea Mongler
Updated: Nov 3rd 2009

new article illustration

TUESDAY, Nov. 3 (HealthDay News) -- The U.S. Food and Drug Administration has revised the label of the type 2 diabetes drug exenatide (Byetta) to provide information about possible kidney function problems, including kidney failure, according to a Nov. 2 press release issued by the agency.

The agency made the changes based on 78 reports of kidney function problems in patients taking Byetta between April 2005 and October 2008. The most common side effects associated with the drug are nausea, diarrhea and vomiting, and it's possible that they contributed to the development of kidney function problems.

The release stated that, from April 2005 to September 2008, nearly seven million Byetta prescriptions were dispensed, so the 78 cases make up a tiny percentage of the patients taking the drug. In addition, some of the patients who reported kidney function problems had pre-existing kidney disease or one or more risk factors for developing kidney problems.

"Health care professionals and patients taking Byetta should pay close attention to any signs or symptoms of kidney problems," Amy Egan, M.D., of the Division of Metabolism and Endocrinology Products at the FDA's Center for Drug Evaluation and Research in Silver Spring, Md., said in a statement. "Patients also should be aware that problems with kidney function could lead to changes in urine color, frequency of urination or the amount of urine, unexplained swelling of the hands or feet, fatigue, changes in appetite or digestion, or dull ache in mid to lower back."

More Information

Follow us on Twitter!

Find us on Facebook!





powered by centersite dot net